近日,全球肿瘤创新公司百济神州宣布欧盟委员会已批准替雷利珠单抗用于三项非小细胞肺癌(NSCLC)适应症的一线及二线治疗。此次获批是替雷利珠单抗在欧盟地区获得的第二项批准,其食管癌领域适...
2024-04-27 20:34:35
2024-04-27 20:34:35
2024-04-27 16:03:23
2024-04-27 13:09:43
2024-04-27 01:29:52
2024-04-26 21:24:17
2024-04-26 19:05:27
2024-04-26 11:15:56
2024-04-26 07:19:37
2024-04-26 04:04:12
2024-04-25 23:35:41
2024-04-25 19:44:49
2024-04-25 15:06:58
2024-04-25 11:50:58
2024-04-25 03:24:14
2024-04-24 20:10:03
2024-04-24 16:39:41
2024-04-24 13:43:33
2024-04-24 08:52:00
2024-04-24 05:10:10
2024-04-24 00:51:22